The Gut and Energy Balance: Visceral Allies in the Obesity Wars

In addition to digesting and assimilating nutrients, the intestine and associated visceral organs play a key sensing and signaling role in the physiology of energy homeostasis. The gut, the pancreatic islets of Langerhans, elements in the portal vasculature, and even visceral adipose tissue communicate with the controllers of energy balance in the brain by means of neural and endocrine pathways. Signals reflecting energy stores, recent nutritional state, and other parameters are integrated in the central nervous system, particularly in the hypothalamus, to coordinate energy intake and expenditure. Our understanding of regulatory neural circuits and the signaling molecules that influence them has progressed rapidly, particularly after the discovery of the adipocyte hormone leptin. These discoveries have led to exploration of novel routes for obesity control, some of which involve gut-derived pathways.

[1]  刘金明,et al.  IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW,Thompson RW,et al//Proc Natl Acad Sci U S A , 2005 .

[2]  T. Moran,et al.  Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[3]  M. Matsuda,et al.  Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin , 2005, Science.

[4]  J. Rungby,et al.  Amylin agonists: a novel approach in the treatment of diabetes. , 2004, Diabetes.

[5]  M. Reilly,et al.  An Inflammatory Cascade Leading to Hyperresistinemia in Humans , 2004, PLoS medicine.

[6]  J. Flier,et al.  Suppressor of Cytokine Signaling 3 Is a Physiological Regulator of Adipocyte Insulin Signaling* , 2004, Journal of Biological Chemistry.

[7]  H. Bays Current and investigational antiobesity agents and obesity therapeutic treatment targets. , 2004, Obesity research.

[8]  D. Drucker,et al.  Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. , 2004, Gastroenterology.

[9]  J. Flier,et al.  Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3 , 2004, Nature Medicine.

[10]  G. Frost,et al.  Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. , 2004, The Journal of clinical endocrinology and metabolism.

[11]  J. Flier,et al.  Adipose tissue as an endocrine organ. , 2004, The Journal of clinical endocrinology and metabolism.

[12]  Mohammad A Ghatei,et al.  Peripheral oxyntomodulin reduces food intake and body weight gain in rats. , 2004, Endocrinology.

[13]  Hui Zheng,et al.  Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Steinbrook Surgery for severe obesity. , 2004, The New England journal of medicine.

[15]  J. Flier Obesity Wars Molecular Progress Confronts an Expanding Epidemic , 2004, Cell.

[16]  M. R. Nilsson,et al.  Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes? , 2004, Diabetologia.

[17]  A. Hirschberg,et al.  Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin. , 2003, Obesity research.

[18]  J. Holst,et al.  Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety , 2003, Regulatory Peptides.

[19]  Yuxiang Sun,et al.  Deletion of Ghrelin Impairs neither Growth nor Appetite , 2003, Molecular and Cellular Biology.

[20]  Mohammad A Ghatei,et al.  Oxyntomodulin suppresses appetite and reduces food intake in humans. , 2003, The Journal of clinical endocrinology and metabolism.

[21]  Mohammad A Ghatei,et al.  Inhibition of food intake in obese subjects by peptide YY3-36. , 2003, The New England journal of medicine.

[22]  S. Gaetani,et al.  Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α , 2003, Nature.

[23]  H. Grill,et al.  Hyperphagic effects of brainstem ghrelin administration. , 2003, Diabetes.

[24]  G. Frost,et al.  Pancreatic polypeptide reduces appetite and food intake in humans. , 2003, The Journal of clinical endocrinology and metabolism.

[25]  H. Berthoud,et al.  Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[26]  M. Westerterp-Plantenga,et al.  The effects of enterostatin intake on food intake and energy expenditure , 2003, British Journal of Nutrition.

[27]  F. Reimann,et al.  A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. , 2003, Diabetes.

[28]  Stanley Heshka,et al.  Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study. , 2003, JAMA.

[29]  D. Drucker,et al.  Glucagon-Like Peptide-1-Responsive Catecholamine Neurons in the Area Postrema Link Peripheral Glucagon-Like Peptide-1 with Central Autonomic Control Sites , 2003, The Journal of Neuroscience.

[30]  Noboru Murakami,et al.  The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. , 2002, Gastroenterology.

[31]  F. Reimann,et al.  Glucose-sensing in glucagon-like peptide-1-secreting cells. , 2002, Diabetes.

[32]  Rachel L. Batterham,et al.  Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.

[33]  Yuichiro Yamada,et al.  Inhibition of gastric inhibitory polypeptide signaling prevents obesity , 2002, Nature Medicine.

[34]  E. Dellinger,et al.  Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. , 2002, The New England journal of medicine.

[35]  R. Reidelberger,et al.  Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[36]  Young-Bum Kim,et al.  PTP1B regulates leptin signal transduction in vivo. , 2002, Developmental cell.

[37]  S. H. Young,et al.  Expression of bitter taste receptors of the T2R family in the gastrointestinal tract and enteroendocrine STC-1 cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  F. Lönnqvist,et al.  A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding , 2002, International Journal of Obesity.

[39]  A. Asakawa,et al.  Roles of pancreatic polypeptide in regulation of food intake , 2002, Peptides.

[40]  J. Flier,et al.  A Transgenic Model of Visceral Obesity and the Metabolic Syndrome , 2001, Science.

[41]  P. J. Larsen,et al.  Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. , 2001, Diabetes.

[42]  D. Smith,et al.  Oxyntomodulin inhibits food intake in the rat. , 2001, Endocrinology.

[43]  A. Astrup,et al.  A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[44]  B. Wisse,et al.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. , 2001, Diabetes.

[45]  B. Portha,et al.  Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. , 2001, Diabetes.

[46]  M. Kurian,et al.  The Use of Electrical Stimulation of the Vagus Nerve to Treat Morbid Obesity , 2001, Epilepsy & Behavior.

[47]  T. Funahashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .

[48]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[49]  M. Nakazato,et al.  A role for ghrelin in the central regulation of feeding , 2001, Nature.

[50]  G. Schwartz,et al.  The role of gastrointestinal vagal afferents in the control of food intake: current prospects. , 2000, Nutrition.

[51]  Rüdiger Klein,et al.  Role of Brain Insulin Receptor in Control of Body Weight and Reproduction , 2000 .

[52]  E. Brown,et al.  L-amino acid sensing by the extracellular Ca2+-sensing receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[54]  A. Prentice,et al.  Effects of recombinant leptin therapy in a child with congenital leptin deficiency. , 1999, The New England journal of medicine.

[55]  A. Bado,et al.  The stomach is a source of leptin , 1998, Nature.

[56]  A. Joyner,et al.  Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.

[57]  C. Mantzoros,et al.  Role of leptin in the neuroendocrine response to fasting , 1996, Nature.

[58]  A. Mccarthy Development , 1996, Current Opinion in Neurobiology.

[59]  R. Pederson,et al.  Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. , 1995, Endocrinology.

[60]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[61]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[62]  A. Masclee,et al.  Bombesin reduces food intake in lean man by a cholecystokinin-independent mechanism. , 1993, The Journal of clinical endocrinology and metabolism.

[63]  F. Pi‐Sunyer,et al.  Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man , 1988, Physiology & Behavior.

[64]  I. Forgacs GASTROENTEROLOGY , 1988, The Lancet.

[65]  S. Bloom,et al.  GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN , 1987, The Lancet.

[66]  G. P. Smith,et al.  Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. , 1981, Science.

[67]  S. Woods,et al.  Peptides and the control of meal size , 1981, Diabetologia.

[68]  C. Baile,et al.  Obese mice and the satiety effects of cholecystokinin, bombesin and pancreatic polypeptide , 1981, Physiology & Behavior.

[69]  T. Emery,et al.  Peptides , 1964, Peptides.

[70]  Anne Hardy,et al.  Nutrition , 1941, The Lancet.

[71]  G. Tsujimoto,et al.  Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 , 2005, Nature Medicine.

[72]  Jiande D. Z. Chen,et al.  Pyloric electrical stimulation reduces food intake by inhibiting gastric motility in dogs. , 2005, Gastroenterology.

[73]  M. Bessler,et al.  Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. , 2005, The Journal of clinical endocrinology and metabolism.

[74]  B. Wolfe,et al.  Surgical treatment of obesity: pyloric electrical stimulation. , 2005, Gastroenterology.

[75]  S. Woods,et al.  Insulin and leptin as adiposity signals. , 2004, Recent progress in hormone research.

[76]  S. Bloom,et al.  Repeated Intracerebroventricular Administration of Glucagon-Like Peptide-1-(7-36) Amide or Exendin-(9-39) Alters Body Weight in the Rat* *This work was supported by the United Kingdom Medical Research Council. , 1999, Endocrinology.